American Association for Clinical Chemistry
Better health through laboratory medicine
Webinars

Sort List of Events By:
Addressing the Analytical, Therapeutic, and Legal Implications of Neonate Drug Testing
Tuesday
April 29, 2014




Addressing the Analytical, Therapeutic, and Legal Implications of Neonate Drug Testing is part of the 2014 Seattle Children's Hospital Series of webinars. Attend this webinar and understand the population-specific challenges involved in...

1.00 Credits

Mass Spectrometry Applications in Designer Drugs of Abuse Testing
Tuesday
April 29, 2014




Mass Spectrometry Applications in Designer Drugs of Abuse Testing is part of AACC’s 2014 Clinical Chemistry webinar series. Liquid chromatography/tandem mass spectrometry (LC-MS/MS) and gas chromatography/ mass spectrometry (GC-MS) methods...

1.0 Credits

The New Clinical Lab Fee Schedule: How Will It Affect Your Lab?
Wednesday
May 07, 2014




Have you finally figured out how Medicare determines what it will pay for clinical laboratory tests? Think again. A new law signed by President Obama on April 1 makes the most significant changes to the clinical laboratory fee schedule that...

1.00 Credits

Mass Spectrometry 101
Tuesday
May 13, 2014




Mass Spectrometry 101 is part of AACC’s 2014 Clinical Chemistry Series of webinars. Dr. Thomas Annesley will cover the basic principles of mass spectrometry in a way that novices will understand and experienced users will appreciate...

1 Credits

Teambuilding for Lab Leaders: When 1+1=11
Thursday
May 15, 2014




In today’s environment, hospitals are being asked to better coordinate patient care to create efficiencies and improve patient outcomes. To do this successfully, teamwork is essential. Register for this program and learn what the goals of teambuilding...

1.00 Credits

Post-Analytical Optimization of Newborn Screening By Tandem Mass Spectrometry
Tuesday
June 10, 2014




Post-analytical Optimization of Newborn Screening by Tandem Mass Spectrometry is part of AACC’s 2014 Clinical Chemistry Series of webinars. Newborn screening technologies have come a long way in the last decade, but there’s still...

1 Credits

The Drive to Define "Normal":The 99th Percentile Value of Cardiac Troponin
Tuesday
July 08, 2014




The Drive to Define “Normal”: The 99th Percentile Value of Cardiac Troponin is part of AACC’s 2014 Clinical Chemistry Series of webinars. The Universal Definition of Myocardial Infarction (MI) includes the typical rise and/or fall of...

1 Credits

Stroke Biomarkers: Current Status, Future Promise
Tuesday
September 02, 2014




Stroke Biomarkers: Current Status, Future Promise is part of AACC’s 2014 Clinical Chemistry Series of webinars. During this informative program, Dr. Robert Christenson will discuss how stroke is currently classified, diagnosed, and...

1.00 Credits

CVD Risk Prediction: The Evolving Role of Laboratory Testing
Tuesday
September 09, 2014




CVD Risk Prediction: The Evolving Role of Laboratory Testing is part of the AACC 2014 Clinical Chemistry webinar series.  In light of new AHA/ACC cholesterol management guidelines released in 2013, what role should lab testing play...

1.0 Credits

Celiac Disease: Advances in Diagnosis and Testing
Tuesday
October 14, 2014




Experts estimate that even though celiac disease affects 1 in 133 people in the U.S., only about 1 in 4,700 are being diagnosed with the disorder. Celebrities who have talked about their diagnoses are raising consumer awareness of the symptoms of...

1.00 Credits

Progress and Challenges in Antiphospholipid Antibody Testing
Tuesday
November 11, 2014




Progress and Challenges in Antiphospholipid Antibody Testing is part of the 2014 Clinical Chemistry Series of webinars. Because of the unique challenges of antiphospholipid testing and results interpretation of results, clinical labs...

1.0 Credits

Current Issues in Laboratory Testing for Rheumatoid Arthritis
Tuesday
December 09, 2014




Current Issues in Laboratory Testing for Rheumatoid Arthritis is part of the 2014 Clinical Chemistry Series of webinars. What do third-generation anti-CCP, anti-CARP and anti-biological therapeutic immunoassays have to offer...

1.0 Credits